| |
|
|
|
Hyatt Regency Bethesda, Bethesda, MD
October 22-23, 2013
The average cost of clinical trials has risen to nearly 60% of total development costs. Patient recruitment delays and a low retention rate are key factors in this increase of costs, leading to a delay in product launch and a subsequent reduction in product exclusivity. Patient recruitment, if not adequately planned and managed, can extend the development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential to obtaining the best data sets for analysis and subsequent filings. In order to optimize both recruitment and retention there needs to be a plan and performance management approach based on evidence, data and a set of tools you know will work. This conference is intended to cover the latest differentiators in recruitment and retention; the newest opportunities in online social networks, EMRs and Big Data to support decision making; evidence-based identification and selection of investigators; recruitment of special populations; and lessons learned from various therapeutic areas. "Evidence-Based, Data-Driven Patient Recruitment and Retention" will provide a comprehensive real-world perspective on this challenging arena, with key takeaways you can implement right away to ensure the best results. - Using Insurance Claims and Electronic Health Records to Ensure a Patient-Centric Trial
- Co-Presentation: Patient Centricity in Developing Strategies for Trial Design and Execution
- Why the Evolution of Site Evaluation/Selection Has Been Counterproductive, and How Industry Must Adapt
- Alternative Approaches and New Collaborative Models for the Pharma Industry to Improve the Quality of Clinical Studies and Bring New Medicines to Patients Faster
- Aligning Strategy and Operations to Accelerate Drug Development
- Benchmarking Patient Recruitment and Retention Practices
- Using Predictive Indicators to Measure Recruitment Vendor Performance
- Case Study: Enrollment Forecasting Pilot
- Challenges and Approaches to Increase Recruitment and Retention of Minority Patients in Clinical Trials
- Setting Achievable Accrual Goals for Minorities and Women: The Significance of Population Demographics for Cancer Researchers
- What Sponsors/CROs Overlook: How Socioeconomic Status, Residential Segregation, and Immigration Patterns Impact Study Enrollment
- Case Study: Pilot Project to Utilize a Social Media Platform for Sponsors and Investigator Site Personnel
- The Impact of Informatics on Clinical Trial Feasibility and Subject Recruitment
- Methods to Improve Clinical Trial Recruitment
- Case Study: Leveraging a Participant-Controlled Registry to Create Cohorts and Enable Clinical Trials
- Technology and Tools that Support Agile, Evidence-Based Recruitment Methods
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute (CHI) |
|
|
Invited Speakers:
|
|
- Bill Gwinn, MBA, Vice President, Clinical Informatics Solutions, OptumInsight
- Christine Dehner, Senior Clinical Trial Manager, Clinical Ops, Seattle Genetics, Inc.
- Adam Chasse, COO, RxTrials
- Robin DeMent, Vice President, R&D-IT, Medicines Development Capabilities, GlaxoSmithKline
- Tania Bojanowski, Director, Development Operations & Strategic Planning, sanofi oncology
- Mary Jo Lamberti, Ph.D., Senior Project Manager, Tufts CSDD, Tufts University
- Elizabeth Mascherino, Associate Director, Clinical Operations, Shire Pharmaceuticals
- Amy Loescher, Director, Clinical Trials Lead, Janssen R&D
- Gerson Peltz, M.D., Medical Director, Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb
- Lynne Nguyen, Director, Population & Community Core, Center for Community-Engaged Translational Research, MD Anderson Cancer Center
- Rebecca Budd, MBA, Managing Director, Navita Clinical Strategy Group
- Chris Conklin, Associate Director, Clinical Research, Global Trial Optimization, Merck
- Damon Michaels, Director, Clinical Trials Research, Vanderbilt University Medical Center
- Janet Flisak, Director, Clinical Research, Johnson & Johnson
- Greg Biggers, Reg4ALL / Genetic Alliance
- Nariman Nasser, Senior Director, Recruitment & Implementation Core, Clinical Research Services, Clinical & Translational Science Institute, University of California San Francisco
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
|
|
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|
|